Novel Interventions in HIV-1 Infection (IMIRC1003)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01130376

Recruitment Status : Terminated (Data from the 12 patients recruited has now been analysed, and it has been determined that it is sufficient to meet the study objectives.)

First Posted : May 26, 2010

Last Update Posted : September 4, 2013

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborator:

Medical Research Council

Information provided by (Responsible Party):

Imperial College London

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Terminated
Actual Primary Completion Date :	October 2011
Actual Study Completion Date :	October 2011

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Herasimtschuk A, Downey J, Nelson M, Moyle G, Mandalia S, Sikut R, Adojaan M, Stanescu I, Gotch F, Imami N. Therapeutic immunisation plus cytokine and hormone therapy improves CD4 T-cell counts, restores anti-HIV-1 responses and reduces immune activation in treated chronic HIV-1 infection. Vaccine. 2014 Dec 5;32(51):7005-7013. doi: 10.1016/j.vaccine.2014.09.072. Epub 2014 Oct 22.

To Top